Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FH1R8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,975
Award facts
- Contract value 100% obligated
- $17,975.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,975.28 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Dupixent 300 mg/2 ml pens with a firm fixed price structure. This contract is a non-set-aside award issued under a competitive procurement process and is scheduled for completion by September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. As a major for-profit pharmaceutical and healthcare solutions provider, the company maintains a robust portfolio of federal contracts covering a comprehensive range of pharmaceutical products, vaccines, medical devices, and specialty healthcare commodities. The parent IDC vehicle enables AmerisourceBergen to supply medications and medical supplies globally to support military healthcare programs, with products encompassing specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The company's contract awards consistently demonstrate competitive capability through open competition and firm fixed pricing arrangements, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FH1R8?
SPE2DB25FH1R8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FH1R8 worth?
The government has obligated $17,975 on SPE2DB25FH1R8.
Is contract SPE2DB25FH1R8 an order under another contract?
Yes. SPE2DB25FH1R8 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH1R8 competed?
The extent of competition for SPE2DB25FH1R8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award